Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $67.34 Analyst target: $98.73 Upside: 46.61%
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.